Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT05039840

Public ClinicalTrials.gov record NCT05039840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of SAR441344 in the Treatment of Systemic Lupus Erythematosus: A Randomized, Double Blind, Placebo-controlled, Phase 2, Proof of Concept Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multinational, randomized, placebo-controlled, parallel treatment, Phase 2, double-blind, 2 arm study evaluating the efficacy and safety of SAR441344 in comparison with placebo in the treatment of participants aged 18 to 70 years with active Systemic Lupus Erythematosus (SLE). Study details include: * Study duration: 36 weeks * Treatment duration: 24 weeks * Visit frequency: every 2 weeks

Study identification

NCT ID
NCT05039840
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
109 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 9, 2021
Primary completion
Sep 2, 2026
Completion
Nov 23, 2026
Last update posted
Aug 5, 2026

2021 – 2026

United States locations

U.S. sites
22
U.S. states
9
U.S. cities
22
Facility City State ZIP Site status
Accel Research Sites Network - Birmingham- Site Number : 8400003 Vestavia Hills Alabama 35216
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler- Site Number : 8400026 Chandler Arizona 85225
Arizona Arthritis & Rheumatology Associates - South Vineyard Avenue- Site Number : 8400022 Mesa Arizona 85210
Arizona Arthritis & Rheumatology Research - Sun City- Site Number : 8400027 Sun City Arizona 85351
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Tucson Southeast- Site Number : 8400023 Tucson Arizona 85748
Saint John's Physician Partners- Site Number : 8400015 Santa Monica California 90404
Millennium Clinical Trials - Simi Valley- Site Number : 8400004 Simi Valley California 93065
Omega Research Consultants - Debary - North Charles Richard Beall Boulevard- Site Number : 8400002 DeBary Florida 32713
Vitalia Medical Research - Margate- Site Number : 8400039 Margate Florida 33063
Innovia Research Center- Site Number : 8400037 Miramar Florida 33027
Integral Rheumatology and Immunology Specialists- Site Number : 8400014 Plantation Florida 33324
Infigo Clinical Research- Site Number : 8400016 Sanford Florida 32771
Inspire Santa Fe Medical Group- Site Number : 8400019 Santa Fe New Mexico 87505
Columbia University Irving Medical Center- Site Number : 8400009 New York New York 10032
RAO - Rheumatology Associates of Oklahoma- Site Number : 8400013 Oklahoma City Oklahoma 73116
Private Practice - Dr. Ramesh C. Gupta I- Site Number : 8400008 Memphis Tennessee 38119
Tekton Research - West Gate- Site Number : 8400001 Austin Texas 78745
Precision Comprehensive Clinical Research Solutions - Colleyville- Site Number : 8400017 Colleyville Texas 76034
Lone Start Arthritis & Rheumatology Associates- Site Number : 8400025 Fort Worth Texas 76109
Prolato Clinical Research Center- Site Number : 8400005 Houston Texas 77054
AARA Clinical Research - Lone Star Arthritis & Rheumatology Associates - Irving- Site Number : 8400024 Irving Texas 75039
West Texas Clinical Research- Site Number : 8400018 Lubbock Texas 79410

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05039840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 5, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05039840 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →